LOGIN
AAOS2019: Similar outcomes with oral and IV TXA for blood loss in thoracolumbar spinal fusion
March 2019
AAOS2019: Similar outcomes with oral and IV TXA for blood loss in thoracolumbar spinal fusion
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Two-Year Outcomes of Patients Treated with Basivertebral Nerve Ablation for the Relief of Chronic Low Back Pain: Results of the SMART Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
171 patients scheduled for an elective posterior thoracolumbar fusion were randomized to receive either intravenous or oral tranexamic acid (TXA). The primary outcome of interest was the reduction in hemoglobin. Secondary outcomes included calculated blood loss, hematocrit drop, drain output, transfusion rate, rate of thromboembolic complications, including deep vein thrombosis and pulmonary embol...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.